Señales en vivo de NAOV | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Stats
Volumen de hoy	15 902.00
Volumen promedio	60 407.00
Capitalización de mercado	2.11M
EPS	$0 ( 2024-04-01 )
Próxima fecha de ganancias	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.360
ATR14	$0.0120 (1.58%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-23	Mika Thomas	Buy	16 666	Option to Purchase Common Stock
2024-01-23	Jacob Harold	Buy	6 667	Option to Purchase Common Stock
2024-01-23	Schroeder Maria	Buy	16 667	Option to Purchase Common Stock
2024-01-23	Ferguson Michael	Buy	16 666	Option to Purchase Common Stock
2024-01-23	Goldstein Martin M	Buy	16 667	Option to Purchase Common Stock

INSIDER POWER
29.17
Last 97 transactions
Buy: 2 103 083 \| Sell: 846 526

Nanovibronix Inc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nanovibronix Inc Finanzas

Annual	2023
Ingresos:	$2.28M
Beneficio Bruto:	$1.54M (67.32 %)
EPS:	$-2.12

FY	2023
Ingresos:	$2.28M
Beneficio Bruto:	$1.54M (67.32 %)
EPS:	$-2.12

FY	2022
Ingresos:	$752 000
Beneficio Bruto:	$167 000 (22.21 %)
EPS:	$-3.84

FY	2021
Ingresos:	$1.70M
Beneficio Bruto:	$770 000 (45.43 %)
EPS:	$-0.570

Financial Reports:

No articles found.

Nanovibronix Inc

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.